Fuller & Thaler Asset Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,525
Closed -$382K 514
2025
Q2
$382K Sell
19,525
-4,400
-18% -$78.2K ﹤0.01% 454
2025
Q1
$425K Buy
23,925
+900
+4% +$19.4K ﹤0.01% 459
2024
Q4
$493K Buy
23,025
+120
+0.5% +$2.92K ﹤0.01% 469
2024
Q3
$715K Buy
+22,905
New +$570K ﹤0.01% 409

Other funds holding CDNA

Fuller & Thaler Asset Management's CDNA Position: Q3 2025 in Review

Fuller & Thaler Asset Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 19,525 shares — an estimated $382K sold.

Fuller & Thaler Asset Management first reported a position in CDNA in Q3 2024 and held it in 4 quarters. The position peaked at $715K in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Fuller & Thaler Asset Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 19,525 CareDx shares in Q3 2025, an estimated $382K.
  • Fuller & Thaler Asset Management first reported a position in CareDx in Q3 2024 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's CareDx position peaked at $715K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.